China probe hangover, functional foods failure depress Usana's earnings

An internal investigation into business practices in China has taken some of the air out of the balloon of Usana Health Sciences, as the company’s stock price declined after an earnings report that was lower than analysts’ estimates. And a launch of a new functional foods line seems to have missed the mark.